HilleVax, Inc., (HLVX): Price and Financial Metrics

HilleVax, Inc., (HLVX): $12.98

0.68 (+5.53%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add HLVX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#208 of 360

in industry

HLVX Price/Volume Stats

Current price $12.98 52-week high $20.22
Prev. close $12.30 52-week low $9.94
Day low $12.21 Volume 88,300
Day high $13.40 Avg. volume 137,155
50-day MA $15.95 Dividend yield N/A
200-day MA $14.38 Market Cap 645.38M

HLVX Stock Price Chart Interactive Chart >


HilleVax, Inc., (HLVX) Company Bio


HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.


HLVX Latest News Stream


Event/Time News Detail
Loading, please wait...

HLVX Latest Social Stream


Loading social stream, please wait...

View Full HLVX Social Stream

Latest HLVX News From Around the Web

Below are the latest news stories about HILLEVAX INC that investors may wish to consider to help them evaluate HLVX as an investment opportunity.

Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 10,000 Shares of HilleVax Inc ...

In a notable insider transaction, Chief Medical Officer Astrid Borkowski sold 10,000 shares of HilleVax Inc (NASDAQ:HLVX) on December 15, 2023.

Yahoo | December 19, 2023

Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 20,000 Shares of HilleVax Inc ...

In a notable insider transaction, Chief Medical Officer Astrid Borkowski sold 20,000 shares of HilleVax Inc (NASDAQ:HLVX) on December 4, 2023.

Yahoo | December 6, 2023

Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to Trade

The mean of analysts' price targets for HilleVax, Inc. (HLVX) points to a 92.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | November 30, 2023

HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade

HilleVax, Inc. (HLVX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | November 14, 2023

Does HilleVax, Inc. (HLVX) Have the Potential to Rally 107.23% as Wall Street Analysts Expect?

The mean of analysts' price targets for HilleVax, Inc. (HLVX) points to a 107.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | November 14, 2023

Read More 'HLVX' Stories Here

HLVX Price Returns

1-mo -22.51%
3-mo -10.73%
6-mo 16.20%
1-year -6.15%
3-year N/A
5-year N/A
YTD -19.13%
2023 -4.06%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!